City

East Hanover (1)

Condition

BRAF v600 Mutated Metastatic Melanoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

Study Documents

Intervention Type

Funder Type

Industry (1)

Study Type

Observational (1)

braf v600 mutated metastatic melanoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Associated Factors, and Clinical Outcomes of Prescribing

Completed

BRAF v600 Mutated Metastatic Melanoma

East Hanover, New Jersey

Novartis Pharmaceuticals

Mar 28, 2023